Gass, P., Untch, M., Müller, V., Möbus, V., Thomssen, C., Häberle, L., . . . Nabieva, N. (2018). Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians. Geburtshilfe Frauenheilkd.
Chicago Style CitationGass, Paul, et al. "Using Probability for Pathological Complete Response (pCR) As a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians." Geburtshilfe Frauenheilkd 2018.
Cita MLAGass, Paul, et al. "Using Probability for Pathological Complete Response (pCR) As a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians." Geburtshilfe Frauenheilkd 2018.